MXPA03003592A - Uso de la tolerancia en el tratamiento del asma. - Google Patents

Uso de la tolerancia en el tratamiento del asma.

Info

Publication number: MXPA03003592A
Authority: MX; Mexico
Prior art keywords: tolterodine; treat asthma; asthma; treat
Prior art date: 2000-10-24

Application number

MXPA03003592A

Other languages

English (en)

Inventor

Sue K Cammarata

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-24

Filing date

2001-10-23

Publication date

2003-06-19

2001-10-23 Application filed by Upjohn Co filed Critical Upjohn Co

2003-06-19 Publication of MXPA03003592A publication Critical patent/MXPA03003592A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Separation Using Semi-Permeable Membranes (AREA)

MXPA03003592A 2000-10-24 2001-10-23 Uso de la tolerancia en el tratamiento del asma. MXPA03003592A (es)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US24289900P	2000-10-24	2000-10-24
US28312001P	2001-04-11	2001-04-11
US31421801P	2001-08-22	2001-08-22
PCT/US2001/027779 WO2002034245A2 (en)	2000-10-24	2001-10-23	Use of tolterodine to treat asthma

Publications (1)

Publication Number	Publication Date
MXPA03003592A true MXPA03003592A (es)	2003-06-19

Family

ID=27399612

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03003592A MXPA03003592A (es)	2000-10-24	2001-10-23	Uso de la tolerancia en el tratamiento del asma.

Country Status (9)

Country	Link
US (1)	US6538035B2 (es)
EP (1)	EP1330241A2 (es)
JP (1)	JP2004513099A (es)
AR (1)	AR031032A1 (es)
AU (1)	AU2002212962A1 (es)
CA (1)	CA2422901A1 (es)
MX (1)	MXPA03003592A (es)
PE (1)	PE20020547A1 (es)
WO (1)	WO2002034245A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9203318D0 (sv) *	1992-11-06	1992-11-06	Kabi Pharmacia Ab	Novel 3,3-diphenylpropylamines, their use and preparation
ES2315425T3 (es) *	2001-10-26	2009-04-01	PHARMACIA & UPJOHN COMPANY LLC	Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos.
US20030144352A1 (en) *	2001-11-05	2003-07-31	Cammarata Sue K.	Antimuscarinic aerosol
BR0307772A (pt) *	2002-02-19	2004-12-07	Pharmacia Corp	Uso de inibidores da ciclooxigenase e de agentes antimuscarìnicos para o tratamento da incontinência
US7005449B2 (en)	2002-04-23	2006-02-28	Pharmacia & Upjohn Company	Tolterodine salts
MXPA05011059A (es) *	2003-04-15	2005-12-12	Pharmacia & Upjohn Co Llc	Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos.
EP1620083A2 (en) *	2003-04-18	2006-02-01	Pharmacia & Upjohn Company LLC	Combination therapies
US7629358B2 (en) *	2004-03-17	2009-12-08	Pfizer Inc	Compounds useful for the treatment of diseases
ES2268987B1 (es)	2005-08-05	2008-02-01	Ragactives, S.L.	Procedimiento para la obtencion de 3,3-difenilpropilaminas.
WO2007107828A2 (en) *	2006-03-20	2007-09-27	Pfizer Limited	Amine derivatives
WO2009019599A2 (en)	2007-08-08	2009-02-12	Themis Laboratories Private Limited	Extended release compositions comprising tolterodine
CA2699463A1 (en) *	2007-09-14	2009-03-19	Pfizer Limited	Novel compounds active as muscarinic receptor antagonists
KR101188333B1 (ko)	2008-02-20	2012-10-09	에스케이케미칼주식회사	안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염
CN110372571B (zh)	2018-04-12	2022-11-15	中国科学院大连化学物理研究所	一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5382600A (en)	1988-01-22	1995-01-17	Pharmacia Aktiebolag	3,3-diphenylpropylamines and pharmaceutical compositions thereof
SE9203318D0 (sv)	1992-11-06	1992-11-06	Kabi Pharmacia Ab	Novel 3,3-diphenylpropylamines, their use and preparation
IL128096A0 (en)	1996-07-29	1999-11-30	Pharmacia & Upjohn Ab	Arylcycloalkane carboxylic esters their use pharmaceutical compositions and preparation
KR20000057548A (ko)	1996-12-13	2000-09-25	알프레드 엘. 미첼슨	광학적 전송물질 및 결합재

2001
- 2001-10-18 PE PE2001001035A patent/PE20020547A1/es not_active Application Discontinuation
- 2001-10-22 AR ARP010104944A patent/AR031032A1/es unknown
- 2001-10-23 CA CA002422901A patent/CA2422901A1/en not_active Abandoned
- 2001-10-23 EP EP01981309A patent/EP1330241A2/en not_active Withdrawn
- 2001-10-23 MX MXPA03003592A patent/MXPA03003592A/es unknown
- 2001-10-23 JP JP2002537299A patent/JP2004513099A/ja active Pending
- 2001-10-23 WO PCT/US2001/027779 patent/WO2002034245A2/en not_active Ceased
- 2001-10-23 US US10/045,135 patent/US6538035B2/en not_active Expired - Fee Related
- 2001-10-23 AU AU2002212962A patent/AU2002212962A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1330241A2 (en)	2003-07-30
US6538035B2 (en)	2003-03-25
US20020161054A1 (en)	2002-10-31
CA2422901A1 (en)	2002-05-02
PE20020547A1 (es)	2002-06-12
AU2002212962A1 (en)	2002-05-06
WO2002034245A2 (en)	2002-05-02
AR031032A1 (es)	2003-09-03
JP2004513099A (ja)	2004-04-30

Publication	Publication Date	Title
GB2376902B (en)	2003-06-04	Water purifier
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
GB0028264D0 (en)	2001-01-03	Well treatment
GB0028926D0 (en)	2001-01-10	Improvements relating to skin prickers
HUP0500983A3 (en)	2012-09-28	Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
EP1347980A4 (en)	2005-02-09	RECEPTOR SPECIFIC COMPOUNDS OF ADENOSINE-A1, -A2A, AND-A3 AND USES THEREOF
GB0028269D0 (en)	2001-01-03	Well treatment
MXPA03003592A (es)	2003-06-19	Uso de la tolerancia en el tratamiento del asma.
AU5464601A (en)	2001-09-12	Treatment of scale
MXPA03007653A (es)	2003-12-04	Uso de lp82 para tratar trastornos hematopoyeticos.
HRP20020729A2 (en)	2004-02-29	Treatment of psoriasis
MXPA03004190A (es)	2003-09-22	Tratamiento de trastornos de ansiedad.
AU4838301A (en)	2001-09-24	Treatment of disorders relating to the serotonergic system
GB0022049D0 (en)	2000-10-25	Improvements relating to water treatment
GB2353217B (en)	2001-07-18	Use of ribose to treat fibromyalgia
GB2372782B (en)	2004-09-22	Nasal sprays
EP1303281A4 (en)	2006-02-15	METHODS OF TREATMENT
GB0007228D0 (en)	2000-05-17	Water purifier
ZA200205415B (en)	2003-10-13	Novel therapeutic use of enoxaparin.
TW478381U (en)	2002-03-01	Countercurrent-type water purifier
TW461552U (en)	2001-10-21	Improvement of seven-string ancient lute
GB0213819D0 (en)	2002-07-24	Water treatment preparation
TW422109U (en)	2001-02-11	Improved structure of magnetic-control wheel
TW530829U (en)	2003-05-01	Novel structure of winding-pulling wheel
TW466965U (en)	2001-12-01	Improved structure of water distiller